Literature DB >> 31678502

A distributed multitask multimodal approach for the prediction of Alzheimer's disease in a longitudinal study.

Solale Tabarestani1, Maryamossadat Aghili2, Mohammad Eslami3, Mercedes Cabrerizo3, Armando Barreto3, Naphtali Rishe4, Rosie E Curiel5, David Loewenstein6, Ranjan Duara7, Malek Adjouadi8.   

Abstract

Predicting the progression of Alzheimer's Disease (AD) has been held back for decades due to the lack of sufficient longitudinal data required for the development of novel machine learning algorithms. This study proposes a novel machine learning algorithm for predicting the progression of Alzheimer's disease using a distributed multimodal, multitask learning method. More specifically, each individual task is defined as a regression model, which predicts cognitive scores at a single time point. Since the prediction tasks for multiple intervals are related to each other in chronological order, multitask regression models have been developed to track the relationship between subsequent tasks. Furthermore, since subjects have various combinations of recording modalities together with other genetic, neuropsychological and demographic risk factors, special attention is given to the fact that each modality may experience a specific sparsity pattern. The model is hence generalized by exploiting multiple individual multitask regression coefficient matrices for each modality. The outcome for each independent modality-specific learner is then integrated with complementary information, known as risk factor parameters, revealing the most prevalent trends of the multimodal data. This new feature space is then used as input to the gradient boosting kernel in search for a more accurate prediction. This proposed model not only captures the complex relationships between the different feature representations, but it also ignores any unrelated information which might skew the regression coefficients. Comparative assessments are made between the performance of the proposed method with several other well-established methods using different multimodal platforms. The results indicate that by capturing the interrelatedness between the different modalities and extracting only relevant information in the data, even in an incomplete longitudinal dataset, will yield minimized prediction errors.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Fused sparse group Lasso; Gradient boosting; Longitudinal study; Missing values; Multimodal regression; Multitask learning; Progression

Year:  2019        PMID: 31678502     DOI: 10.1016/j.neuroimage.2019.116317

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  5 in total

1.  A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer's Disease.

Authors:  Solale Tabarestani; Mohammad Eslami; Mercedes Cabrerizo; Rosie E Curiel; Armando Barreto; Naphtali Rishe; David Vaillancourt; Steven T DeKosky; David A Loewenstein; Ranjan Duara; Malek Adjouadi
Journal:  Front Aging Neurosci       Date:  2022-05-06       Impact factor: 5.702

2.  A Long Short-Term Memory Biomarker-Based Prediction Framework for Alzheimer's Disease.

Authors:  Anza Aqeel; Ali Hassan; Muhammad Attique Khan; Saad Rehman; Usman Tariq; Seifedine Kadry; Arnab Majumdar; Orawit Thinnukool
Journal:  Sensors (Basel)       Date:  2022-02-14       Impact factor: 3.576

Review 3.  The Road to Personalized Medicine in Alzheimer's Disease: The Use of Artificial Intelligence.

Authors:  Anuschka Silva-Spínola; Inês Baldeiras; Joel P Arrais; Isabel Santana
Journal:  Biomedicines       Date:  2022-01-29

4.  Early detection of Alzheimer's disease using neuropsychological tests: a predict-diagnose approach using neural networks.

Authors:  Devarshi Mukherji; Manibrata Mukherji; Nivedita Mukherji
Journal:  Brain Inform       Date:  2022-09-27

5.  Prediction and Modeling of Neuropsychological Scores in Alzheimer's Disease Using Multimodal Neuroimaging Data and Artificial Neural Networks.

Authors:  Seyed Hani Hojjati; Abbas Babajani-Feremi
Journal:  Front Comput Neurosci       Date:  2022-01-06       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.